Director/PDMR Shareholding

RNS Number : 2130V
GlaxoSmithKline PLC
09 January 2013
 



 Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

 

 

The Administrators of the GlaxoSmithKline UK and US Performance Share Plans notified the Company and the under-mentioned Connected Persons on 8 January 2013 of the following increases in their notional interests in Ordinary Shares at a price of 1363.50 pence per Ordinary Share and American Depositary Shares (ADSs) at a price of $43.98 per ADS following the notional re-investment of the dividend paid to shareholders on 3 January 2013.

 

 

 

Director/PDMR

 

 

 

Connected Person

 

Ordinary Shares

 

ADSs

 

Dr M M Slaoui

 

 

Dr K Slaoui

 

-

 

22.521

 

Mr P C Thomson

 

 

Mrs K Thomson

 

56.689

 

-

 

 

The notional dividends accrued will be paid out in proportion to the percentage of the participant's Performance Share Plan holdings that vest following the end of the relevant three year measurement period.

 

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).

 

 

V A Whyte

Company Secretary

 

9 January 2013

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSDKLFBXFFLBBZ

Companies

GSK (GSK)
UK 100

Latest directors dealings